Parameters influencing the efficacy of magnetic heating of small breast tumors

Nanomedicine - Basic and Clinical Applications in Diagnostics and Therapy

Volumn , Issue , 2011, Pages 164-176

  Hilger , Ingrid ^a   Kaiser, Werner ^b  

^a Institute of Diagnostic and Interventional Radiology   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNETIC MATERIALS; MAGNETISM; MAGNETITE;

ALTERNATING MAGNETIC FIELD; BREAST TUMOR; MAGNETIC HEATING; MINIMALLY INVASIVE; SELECTIVE HEATING; SMALL TUMORS; THERAPEUTIC EFFICACY; THERAPEUTIC METHOD;

TUMORS;

EID: 84866676252     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783805598194.ch14     Document Type: Chapter

References (66)

1. Sardanelli F, Podo F, Santoro F, Manoukian S, Bergonzi S, Trecate G, Vergnaghi D, Federico M, Cortesi L, Corcione S, Morassut S, Di Maggio C, Cilotti A, Martincich L, Calabrese M, Zuiani C, Preda L, Bonanni B, Carbonaro LA, Contegiacomo A, Panizza P, Di Cesare E, Savarese A, Crecco M, Turchetti D, Tonutti M, Belli P, Maschio AD: Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the High Breast Cancer Risk Italian 1 Study): final results. Invest Radiol 2011;46:94-105.
2. Van Dongen JA, Barteling H, Fentiman IS, et al: Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC Trial 1081, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992;28A:801-805.
3. Zhao Z, Wu F: Minimally-invasive thermal ablation of early-stage breast cancer: a systemic review. Eur J Surg Oncol 2010;36:1149-1155.
4. Gilchrist RK, Medal R, Shorey WD, Hanselman RC, Parrott JC, Taylor CB: Selective inductive heating of lymph nodes. Ann Surg 1957;146:596-606.
5. Gilchrist RK, Shorey WD, Russel M, Hanselman RC, dePeyster FA, Yang J, Medal R: Effects of electromagnetic heating on internal viscera: a preliminary to the treatment of human tumors. Ann Surg 1965;161:890-896.
6. Johannsen M, Gneveckow U, Taymoorian K, Thiesen B, Waldofner N, Scholz R, Jung K, Jordan A, Wust P, Loening SA: Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial. Int J Hyperthermia 2007; 23:315-323.
7. Johannsen M, Thiesen B, Wust P, Jordan A: Magnetic nanoparticle hyperthermia for prostate cancer. Int J Hyperthermia 2010;26:790-795.
8. Bacon BR, Stark DD, Park CH, Saini S, Gromann EV, Hahn PF, Compton CC, Ferrucci JT: Ferrite particles: a new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatoxicity after intravenous administration. J Lab Clin Med 1987;110:164-171.
9. Marchal G, van Heke P, Demaerel P, Decrop E, Kennis C, Baert AL, van der Schuerren E: Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. Am J Radiol 1988;152: 771-775.
10. Rummeny E, Weissleder R, Stark DD, Elizondo G, Ferrucci JT: Kernspintomographie fokaler Leberund Milzläsionen. Radiologe 1988;28:380-386.
11. Hergt R, Andrä W, d'Ambly CG, Hilger I, Kaiser WA, Richter U, Schmidt HG: Physical limits of hyperthermia using magnetite fine particles. IEEE Trans Magn 1998;34:3745-3754.
12. Hilger I, Andrä W, Hergt R, Hiergeist R, Schubert H, Kaiser WA: Electromagnetic heating of breast tumors in interventional radiology: in vitro and in vivo studies in human cadavers and mice. Radiology 2001;218:570-575.
13. Blums E, Cebers A, Maiorov MM: Mag-netic Fluids. New York, de Gruyter,1997.
14. Hergt R, Hiergeist R, Hilger I, Kaiser WA: Magnetic Nanoparticles for Ther-moablation. Recent Res Dev Mater Sci 2002;3:723-742.
15. Andrä W: Magnetic hyperthermia; in Andrä W, Nowak H (eds): Magnetism in Medicine. Berlin, Wiley-VCH, 1998, pp 455-470.
16. Hergt R, Hiergeist R, Hilger I, Kaiser WA, Lapatnikov Y, Margel S, Richter U: Maghemite nanoparticles with very high AC-losses for application in RFmagnetic hyperthermia. J Magn Magn Mater 2004;270:345-357.
17. Fricker J: Drugs with a magnetic attraction to tumours. Drug Discov Today 2001;6:387-389.
18. Hergt R, Hiergeist R, Zeisberger M, Glockl G, Weitschies W, Ramirez P, Hilger I, Kaiser WA: Enhancement of AC-losses of magnetic nanoparticles for heating applications. J Magn Magn Mater 2004;280:358-368.
19. Hergt R, Hiergeist R, Zeisberger M, Schüler D, Heyen U, Hilger I, Kaiser W: Magnetic properties of bacterial magnetosomes as potential diagnostic and therapeutic tools. J Magn Magn Mater 2005;293:80-86.
20. Frimpong RA, Hilt JZ: Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications. Nanomedicine 2010;5:1401-1414.
21. Eberbeck D, Kettering M, Bergemann C, Zirpel P, Hilger I, Trahms L: Quantification of the aggregation of magnetic nanoparticles with different polymeric coatings in cell culture medium. J Phys D Appl Phys 2010;43:405002.
22. Kettering M, Zorn H, Bremer-Streck S, Oehring H, Zeisberger M, Bergemann C, Hergt R, Halbhuber KJ, Kaiser WA, Hilger I: Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications. Phys Med Biol 2009;54:5109-5121.
23. Raaphorst GP, Li LF, Yang DP, LeBlanc JM: Cisplatin sensitization by concurrent mild hyperthermia in parental and mutant cell lines deficient in homologous recombination and non-homologous endjoining repair. Oncol Rep 2005;14:281-285.
24. Wang D, Lippard SJ: Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 2005;4:307-320.
25. Xu P, Van Kirk EA, Li S, Murdoch WJ, Ren J, Hussain MD, Radosz M, Shen Y: Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy. Colloids Surf B Biointerfaces 2006;48:50-57.
26. Kim HR, Andrieux K, Delomenie C, Chacun H, Appel M, Desmaële D, Taran F, Georgin D, Couvreur P, Taverna M: Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system. Electrophoresis 2007;28:2252-2261.
27. Hilger I, Leistner Y, Berndt A, Fritsche C, Haas KM, Kosmehl H, Kaiser WA: Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells. Eur Radiol 2004;14:1124-1129.
28. Hilger I, Trost R, Reichenbach JR, Linss W, Lisy MR, Berndt A, Kaiser WA: MR imaging of Her-2/neu protein using magnetic nanoparticles. Nanotechnology 2007;18:135103.
29. Lisy MR, Goermar A, Thomas C, Pauli J, Resch-Genger U, Kaiser WA, Hilger I: In vivo near-infrared fluorescence imaging of carcinoembryonic antigenexpressing tumor cells in mice. Radiology 2008;247:779-787.
30. Hilger I, Dietmar E, Linss W, Streck S, Kaiser WA: Developments for the minimally invasive treatment of tumours by targeted magnetic heating. J PhysCondens Matter 2006;18:S2951-S2958.
31. Kettering M, Winter J, Zeisberger M, Alexiou C, Bremer-Streck S, Bergemann C, Kaiser WA, Hilger I: Magnetically based enhancement of nanoparticle uptake in tumor cells: combination of magnetically induced cell labeling and magnetic heating (in German). Rofo 2006;178:1255-1260.
32. Hiergeist R, Andrä W, Buske N, Hergt R, Hilger I, Richter U, Kaiser WA: Application of magnetite ferrofluids for hyperthermia. J Magn Magn Mater 1999;201:420-422.
33. Atkinson W, Brezovich I, Chakraborty D: Usable frequencies in hyperthermia with thermal seeds. IEEE Trans Biomed Eng 1984;31:70-75.
34. Brezovich I: Low frequency hyperthermia: capacitive and ferromagnetic thermoseed methods; in Palival P, Hetzel FW (eds): Medical Physics Monograph. New York, American Institute of Physics, 1988, pp 82-111.
35. Jordan A, Scholz R, Maier-Hauff K, Johannsen M, Wust P, Nadobny J, Schirra H, Schmidt H, Deger S, Loening S, Lanksch W, Felix R: Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J Magn Magn Mater 2001;225:118-126.
36. Hilger I, Frühauf S, Andrä W, Hiergeist R, Hergt R, Kaiser WA: Magnetic heating as a therapeutic tool. Thermology Int 2001;11:130-136.
37. Ritchie KP, Keller BM, Syed KM, Lepock JR: Hyperthermia (heat shock)induced protein denaturation in liver, muscle and lens tissue as determined by differential scanning calorimetry. Int J Hyperthermia 1994;10:605-618.
38. Joly MA: A Physico-Chemical Approach to Denaturation of Proteins. New York, Academic Press, 1965.
39. Xu Y, Qian R: Analysis of thermal injury process based on enzyme deactivation mechanisms. J Biomech Eng 1995; 117:462-465.
40. Heisterkamp J, van Hillegersberg R, IJzermans JN: Critical temperature and heating time for coagulation damage: implications for interstitial laser coagulation (ILC) of tumors. Lasers Surg Med 1999;25:257-262.
41. Hilger I, Andrä W, Bähring R, Daum A, Hergt R, Kaiser WA: Evaluation of temperature increase with different amounts of magnetite in liver tissue samples. Invest Radiol 1997;32:705-712.
42. Hunt MC, Sørheim O, Slinde E: Color and heat denaturation of myoglobin forms in ground beef. J Food Sci 1999; 64:847-851.
43. Hilger I, Rapp A, Greulich KO, Kaiser WA: Assessment of DNA damage in target tumor cells after thermoablation in mice. Radiology 2005;237:500-506.
44. Rabin Y: Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense? Int J Hyperthermia 2002;18:194-202.
45. Jordan A, Scholz R, Wust P, Schirra H, Schiestel T, Schmidt H, Felix R: Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J Magn Magn Mater 1999;194:185-196.
46. Li Z, Vogel M, Maccarini P, Stakhursky V, Soher B, Craciunescu O, Das S, Arabe O, Joines W, Stauffer P: Improved hyperthermia treatment control using SAR/temperature simulation and PRFS magnetic resonance thermal imaging. Int J Hyperthermia 2011;27:86-99.
47. Hilger I, Hiergeist R, Hergt R, Winnefeld K, Schubert H, Kaiser WA: Thermoablation of tumors using magnetic nanoparticles: an in vivo feasibility study. Invest Radiol 2002;37:580-586.
48. Jordan A, Scholz R, Wust P, Fähling H, Krause J, Wlodarczyk W, Sander B, Vogl T, Felix R: Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. Int J Hyperthermia 1997;13:587-605.
49. Tannock IF, Steel GG: Quantitative techniques for study of the anatomy and function of small blood vessels in tumors. J Natl Cancer Inst 1969;42: 771-782.
50. Solesvik OV, Rofstad EK, Brustad T: Vascular structure of five human malignant melanomas grown in athymic nude mice. Br J Cancer 1982;46:557-567.
51. Hirano A, Matsui T: Vascular structure in brain tumors. Hum Pathol 1975;6: 611-621.
52. Warren BA: The vascular morphology of tumors; in Peterson HI (ed): Tumor Blood Circulation. Boca Raton, CRC Press, 1979, pp 1-47.
53. Hammersen F, Endrich B, Messmer K: The fine structure of tumor blood vessels. 1. Participation of non-endothelial cells in tumor angiogenensis. Int J Microcirc Clin Exp 1985;4:31-43.
54. Reinhold HS: Physiological effects of hyperthermia. Recent Results Cancer Res 1988;107:32-43.
55. Lu XQ, Burdette EC, Bornstein BA, Hansen JL, Svensson GK: Design of an ultrasonic therapy system for breast cancer treatment. Int J Hyperthermia 1996;12:375-399.
56. Waterman FM, Nerlinger RE, Moylan DJ, Leeper DB: Response of human tumor blood flow to local hyperthermia. Int J Radiat Oncol Biol Phys 1987;13: 75-82.
57. Dewhirst M, Gross JF, Sim D, Arnold P, Boyer D: The effect of rate of heating or cooling prior to heating on tumour and normal tissue microcirculatory blood flow. Biorheology 1984a; 21:539-558.
58. Dewhirst MW, Sim DA, Gross J, Kundrat MA: Effect of heating rate on tumour and normal tissue microcirculatory function; in Overgaard J (ed): Hyperthermic Oncology. London, Taylor and Francis, 1984, pp 177-180.
59. Reinhold HS, Endrich B: Invited review: tumour microcirculation as a target for hyperthermia. Int J Hyperthermia 1986;2:11-137.
60. Roti JL: Cellular responses to hyperthermia (40-46 degrees C): cell killing and molecular events. Int J Hyperthermia 2008;24:3-15.
61. Babincová M, Leszczynska D, Sourivong P, Babinec P: Selective treatment of neoplastic cells using ferritin-mediated electromagnetic hyperthermia. Med Hypotheses 2000 54:177-179.
62. Buyukhatipoglu K, Clyne AM: Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation. J Biomed Mater Res A 2011;96:186-195.
63. Multhoff G, Gaipl U: Molecular and immunological effects of hyperthermia on tumor progression and metastasis. Onkologe 2010;16:1043-1050.
64. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T: Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Jpn J Cancer Res 1998;89:775-782.
65. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J: Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989;152: 167-173.
66. Klausner RD, Ronault TA, Harford JB: Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 1993;72:12-28.